nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Topotecan—ovarian cancer	0.112	0.354	CbGbCtD
Budesonide—CYP3A4—Vinorelbine—ovarian cancer	0.0792	0.249	CbGbCtD
Budesonide—CYP3A4—Paclitaxel—ovarian cancer	0.0557	0.175	CbGbCtD
Budesonide—CYP3A4—Docetaxel—ovarian cancer	0.0403	0.127	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—ovarian cancer	0.03	0.0944	CbGbCtD
Budesonide—Betamethasone—PGR—ovarian cancer	0.00183	0.269	CrCbGaD
Budesonide—Dexamethasone—PGR—ovarian cancer	0.00106	0.156	CrCbGaD
Budesonide—Dexamethasone—CYP1B1—ovarian cancer	0.000995	0.146	CrCbGaD
Budesonide—Methylprednisolone—ABCB1—ovarian cancer	0.00071	0.104	CrCbGaD
Budesonide—Dysuria—Epirubicin—ovarian cancer	0.00063	0.000933	CcSEcCtD
Budesonide—Rash—Vinorelbine—ovarian cancer	0.000628	0.00093	CcSEcCtD
Budesonide—Dermatitis—Vinorelbine—ovarian cancer	0.000628	0.000929	CcSEcCtD
Budesonide—Abdominal distension—Doxorubicin—ovarian cancer	0.000628	0.000929	CcSEcCtD
Budesonide—Headache—Vinorelbine—ovarian cancer	0.000624	0.000924	CcSEcCtD
Budesonide—Syncope—Docetaxel—ovarian cancer	0.000624	0.000924	CcSEcCtD
Budesonide—Influenza—Doxorubicin—ovarian cancer	0.000624	0.000923	CcSEcCtD
Budesonide—Pollakiuria—Epirubicin—ovarian cancer	0.000623	0.000922	CcSEcCtD
Budesonide—Palpitations—Docetaxel—ovarian cancer	0.000615	0.000911	CcSEcCtD
Budesonide—Weight increased—Epirubicin—ovarian cancer	0.000613	0.000908	CcSEcCtD
Budesonide—Loss of consciousness—Docetaxel—ovarian cancer	0.000612	0.000906	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000611	0.000904	CcSEcCtD
Budesonide—Cough—Docetaxel—ovarian cancer	0.000608	0.000899	CcSEcCtD
Budesonide—Insomnia—Paclitaxel—ovarian cancer	0.000606	0.000898	CcSEcCtD
Budesonide—Paraesthesia—Paclitaxel—ovarian cancer	0.000602	0.000891	CcSEcCtD
Budesonide—Hypertension—Docetaxel—ovarian cancer	0.000601	0.00089	CcSEcCtD
Budesonide—Infestation NOS—Epirubicin—ovarian cancer	0.000601	0.00089	CcSEcCtD
Budesonide—Infestation—Epirubicin—ovarian cancer	0.000601	0.00089	CcSEcCtD
Budesonide—Bronchitis—Doxorubicin—ovarian cancer	0.0006	0.000888	CcSEcCtD
Budesonide—Dyspnoea—Paclitaxel—ovarian cancer	0.000598	0.000885	CcSEcCtD
Budesonide—Somnolence—Paclitaxel—ovarian cancer	0.000596	0.000882	CcSEcCtD
Budesonide—Myalgia—Docetaxel—ovarian cancer	0.000593	0.000878	CcSEcCtD
Budesonide—Chest pain—Docetaxel—ovarian cancer	0.000593	0.000878	CcSEcCtD
Budesonide—Arthralgia—Docetaxel—ovarian cancer	0.000593	0.000878	CcSEcCtD
Budesonide—Nausea—Vinorelbine—ovarian cancer	0.000592	0.000876	CcSEcCtD
Budesonide—Dyspepsia—Paclitaxel—ovarian cancer	0.00059	0.000874	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000589	0.000871	CcSEcCtD
Budesonide—Conjunctivitis—Epirubicin—ovarian cancer	0.000584	0.000865	CcSEcCtD
Budesonide—Urinary tract infection—Epirubicin—ovarian cancer	0.000584	0.000865	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—ovarian cancer	0.000583	0.000863	CcSEcCtD
Budesonide—Decreased appetite—Paclitaxel—ovarian cancer	0.000583	0.000863	CcSEcCtD
Budesonide—Dry mouth—Docetaxel—ovarian cancer	0.00058	0.000858	CcSEcCtD
Budesonide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000579	0.000857	CcSEcCtD
Budesonide—Fatigue—Paclitaxel—ovarian cancer	0.000578	0.000856	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—ovarian cancer	0.000576	0.000853	CcSEcCtD
Budesonide—Constipation—Paclitaxel—ovarian cancer	0.000573	0.000849	CcSEcCtD
Budesonide—Pain—Paclitaxel—ovarian cancer	0.000573	0.000849	CcSEcCtD
Budesonide—Haematuria—Epirubicin—ovarian cancer	0.000573	0.000848	CcSEcCtD
Budesonide—Confusional state—Docetaxel—ovarian cancer	0.000573	0.000848	CcSEcCtD
Budesonide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000568	0.000841	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—ovarian cancer	0.000568	0.00084	CcSEcCtD
Budesonide—Epistaxis—Epirubicin—ovarian cancer	0.000567	0.000839	CcSEcCtD
Budesonide—Infection—Docetaxel—ovarian cancer	0.000565	0.000836	CcSEcCtD
Budesonide—Sinusitis—Epirubicin—ovarian cancer	0.000564	0.000835	CcSEcCtD
Budesonide—Shock—Docetaxel—ovarian cancer	0.000559	0.000828	CcSEcCtD
Budesonide—Nervous system disorder—Docetaxel—ovarian cancer	0.000557	0.000825	CcSEcCtD
Budesonide—Infestation NOS—Doxorubicin—ovarian cancer	0.000556	0.000823	CcSEcCtD
Budesonide—Infestation—Doxorubicin—ovarian cancer	0.000556	0.000823	CcSEcCtD
Budesonide—Tachycardia—Docetaxel—ovarian cancer	0.000555	0.000821	CcSEcCtD
Budesonide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000552	0.000818	CcSEcCtD
Budesonide—Skin disorder—Docetaxel—ovarian cancer	0.000552	0.000817	CcSEcCtD
Budesonide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000548	0.000812	CcSEcCtD
Budesonide—Prednisone—ABCB1—ovarian cancer	0.000543	0.0799	CrCbGaD
Budesonide—Haemoglobin—Epirubicin—ovarian cancer	0.000542	0.000803	CcSEcCtD
Budesonide—Anorexia—Docetaxel—ovarian cancer	0.000542	0.000802	CcSEcCtD
Budesonide—Rhinitis—Epirubicin—ovarian cancer	0.000541	0.000801	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—ovarian cancer	0.00054	0.0008	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—ovarian cancer	0.00054	0.0008	CcSEcCtD
Budesonide—Haemorrhage—Epirubicin—ovarian cancer	0.000539	0.000799	CcSEcCtD
Budesonide—Pharyngitis—Epirubicin—ovarian cancer	0.000535	0.000793	CcSEcCtD
Budesonide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000533	0.000789	CcSEcCtD
Budesonide—Urticaria—Paclitaxel—ovarian cancer	0.000533	0.000788	CcSEcCtD
Budesonide—Oedema peripheral—Epirubicin—ovarian cancer	0.000531	0.000787	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—ovarian cancer	0.00053	0.000785	CcSEcCtD
Budesonide—Connective tissue disorder—Epirubicin—ovarian cancer	0.00053	0.000785	CcSEcCtD
Budesonide—Abdominal pain—Paclitaxel—ovarian cancer	0.00053	0.000785	CcSEcCtD
Budesonide—Body temperature increased—Paclitaxel—ovarian cancer	0.00053	0.000785	CcSEcCtD
Budesonide—Urethral disorder—Epirubicin—ovarian cancer	0.000529	0.000783	CcSEcCtD
Budesonide—Epistaxis—Doxorubicin—ovarian cancer	0.000524	0.000776	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—ovarian cancer	0.000522	0.000772	CcSEcCtD
Budesonide—Visual impairment—Epirubicin—ovarian cancer	0.00052	0.00077	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000518	0.000766	CcSEcCtD
Budesonide—Insomnia—Docetaxel—ovarian cancer	0.000514	0.000761	CcSEcCtD
Budesonide—Paraesthesia—Docetaxel—ovarian cancer	0.00051	0.000755	CcSEcCtD
Budesonide—Dyspnoea—Docetaxel—ovarian cancer	0.000507	0.00075	CcSEcCtD
Budesonide—Somnolence—Docetaxel—ovarian cancer	0.000505	0.000748	CcSEcCtD
Budesonide—Eye disorder—Epirubicin—ovarian cancer	0.000504	0.000746	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—ovarian cancer	0.000502	0.000743	CcSEcCtD
Budesonide—Prednisolone—ABCB1—ovarian cancer	0.000501	0.0736	CrCbGaD
Budesonide—Cardiac disorder—Epirubicin—ovarian cancer	0.000501	0.000741	CcSEcCtD
Budesonide—Flushing—Epirubicin—ovarian cancer	0.000501	0.000741	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—ovarian cancer	0.0005	0.000741	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—ovarian cancer	0.0005	0.00074	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—ovarian cancer	0.000499	0.000739	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—ovarian cancer	0.000495	0.000733	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—ovarian cancer	0.000494	0.000731	CcSEcCtD
Budesonide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000494	0.000731	CcSEcCtD
Budesonide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000493	0.00073	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—ovarian cancer	0.000492	0.000728	CcSEcCtD
Budesonide—Betamethasone—ABCB1—ovarian cancer	0.000491	0.0721	CrCbGaD
Budesonide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000491	0.000726	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000491	0.000726	CcSEcCtD
Budesonide—Fatigue—Docetaxel—ovarian cancer	0.00049	0.000725	CcSEcCtD
Budesonide—Angiopathy—Epirubicin—ovarian cancer	0.000489	0.000725	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—ovarian cancer	0.000489	0.000724	CcSEcCtD
Budesonide—Immune system disorder—Epirubicin—ovarian cancer	0.000487	0.000721	CcSEcCtD
Budesonide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000486	0.00072	CcSEcCtD
Budesonide—Pain—Docetaxel—ovarian cancer	0.000486	0.000719	CcSEcCtD
Budesonide—Constipation—Docetaxel—ovarian cancer	0.000486	0.000719	CcSEcCtD
Budesonide—Visual impairment—Doxorubicin—ovarian cancer	0.000481	0.000712	CcSEcCtD
Budesonide—Asthenia—Paclitaxel—ovarian cancer	0.000481	0.000712	CcSEcCtD
Budesonide—Alopecia—Epirubicin—ovarian cancer	0.000477	0.000706	CcSEcCtD
Budesonide—Pruritus—Paclitaxel—ovarian cancer	0.000474	0.000702	CcSEcCtD
Budesonide—Mental disorder—Epirubicin—ovarian cancer	0.000473	0.0007	CcSEcCtD
Budesonide—Malnutrition—Epirubicin—ovarian cancer	0.00047	0.000695	CcSEcCtD
Budesonide—Feeling abnormal—Docetaxel—ovarian cancer	0.000468	0.000693	CcSEcCtD
Budesonide—Eye disorder—Doxorubicin—ovarian cancer	0.000466	0.000691	CcSEcCtD
Budesonide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000465	0.000688	CcSEcCtD
Budesonide—Flushing—Doxorubicin—ovarian cancer	0.000463	0.000686	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000463	0.000686	CcSEcCtD
Budesonide—Flatulence—Epirubicin—ovarian cancer	0.000463	0.000685	CcSEcCtD
Budesonide—Tension—Epirubicin—ovarian cancer	0.000461	0.000682	CcSEcCtD
Budesonide—Dysgeusia—Epirubicin—ovarian cancer	0.00046	0.000681	CcSEcCtD
Budesonide—Diarrhoea—Paclitaxel—ovarian cancer	0.000459	0.000679	CcSEcCtD
Budesonide—Nervousness—Epirubicin—ovarian cancer	0.000456	0.000675	CcSEcCtD
Budesonide—Back pain—Epirubicin—ovarian cancer	0.000454	0.000672	CcSEcCtD
Budesonide—Angiopathy—Doxorubicin—ovarian cancer	0.000453	0.00067	CcSEcCtD
Budesonide—Muscle spasms—Epirubicin—ovarian cancer	0.000451	0.000668	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—ovarian cancer	0.000451	0.000667	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00045	0.000666	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—ovarian cancer	0.000449	0.000665	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—ovarian cancer	0.000449	0.000665	CcSEcCtD
Budesonide—Dizziness—Paclitaxel—ovarian cancer	0.000443	0.000656	CcSEcCtD
Budesonide—Vision blurred—Epirubicin—ovarian cancer	0.000443	0.000655	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—ovarian cancer	0.000441	0.000653	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—ovarian cancer	0.000437	0.000647	CcSEcCtD
Budesonide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000436	0.000645	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—ovarian cancer	0.000435	0.000643	CcSEcCtD
Budesonide—Anaemia—Epirubicin—ovarian cancer	0.000434	0.000643	CcSEcCtD
Budesonide—Agitation—Epirubicin—ovarian cancer	0.000432	0.000639	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—ovarian cancer	0.000428	0.000634	CcSEcCtD
Budesonide—Tension—Doxorubicin—ovarian cancer	0.000426	0.000631	CcSEcCtD
Budesonide—Vomiting—Paclitaxel—ovarian cancer	0.000426	0.000631	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—ovarian cancer	0.000426	0.00063	CcSEcCtD
Budesonide—Malaise—Epirubicin—ovarian cancer	0.000423	0.000627	CcSEcCtD
Budesonide—Rash—Paclitaxel—ovarian cancer	0.000423	0.000626	CcSEcCtD
Budesonide—Dermatitis—Paclitaxel—ovarian cancer	0.000422	0.000625	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—ovarian cancer	0.000422	0.000625	CcSEcCtD
Budesonide—Vertigo—Epirubicin—ovarian cancer	0.000422	0.000625	CcSEcCtD
Budesonide—Syncope—Epirubicin—ovarian cancer	0.000421	0.000623	CcSEcCtD
Budesonide—Back pain—Doxorubicin—ovarian cancer	0.00042	0.000622	CcSEcCtD
Budesonide—Headache—Paclitaxel—ovarian cancer	0.00042	0.000622	CcSEcCtD
Budesonide—Hypersensitivity—Docetaxel—ovarian cancer	0.000419	0.00062	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—ovarian cancer	0.000418	0.000618	CcSEcCtD
Budesonide—Palpitations—Epirubicin—ovarian cancer	0.000415	0.000614	CcSEcCtD
Budesonide—Loss of consciousness—Epirubicin—ovarian cancer	0.000413	0.000611	CcSEcCtD
Budesonide—Cough—Epirubicin—ovarian cancer	0.00041	0.000607	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—ovarian cancer	0.00041	0.000606	CcSEcCtD
Budesonide—Asthenia—Docetaxel—ovarian cancer	0.000408	0.000604	CcSEcCtD
Budesonide—Hypertension—Epirubicin—ovarian cancer	0.000405	0.0006	CcSEcCtD
Budesonide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000403	0.000597	CcSEcCtD
Budesonide—Pruritus—Docetaxel—ovarian cancer	0.000402	0.000595	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—ovarian cancer	0.000402	0.000595	CcSEcCtD
Budesonide—Arthralgia—Epirubicin—ovarian cancer	0.0004	0.000592	CcSEcCtD
Budesonide—Myalgia—Epirubicin—ovarian cancer	0.0004	0.000592	CcSEcCtD
Budesonide—Chest pain—Epirubicin—ovarian cancer	0.0004	0.000592	CcSEcCtD
Budesonide—Agitation—Doxorubicin—ovarian cancer	0.000399	0.000591	CcSEcCtD
Budesonide—Anxiety—Epirubicin—ovarian cancer	0.000398	0.00059	CcSEcCtD
Budesonide—Nausea—Paclitaxel—ovarian cancer	0.000398	0.00059	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000397	0.000588	CcSEcCtD
Budesonide—Discomfort—Epirubicin—ovarian cancer	0.000395	0.000585	CcSEcCtD
Budesonide—Malaise—Doxorubicin—ovarian cancer	0.000392	0.00058	CcSEcCtD
Budesonide—Dry mouth—Epirubicin—ovarian cancer	0.000391	0.000579	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—ovarian cancer	0.00039	0.000578	CcSEcCtD
Budesonide—Syncope—Doxorubicin—ovarian cancer	0.00039	0.000577	CcSEcCtD
Budesonide—Diarrhoea—Docetaxel—ovarian cancer	0.000389	0.000576	CcSEcCtD
Budesonide—Confusional state—Epirubicin—ovarian cancer	0.000386	0.000572	CcSEcCtD
Budesonide—Palpitations—Doxorubicin—ovarian cancer	0.000384	0.000568	CcSEcCtD
Budesonide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000383	0.000567	CcSEcCtD
Budesonide—Hydrocortisone—ABCB1—ovarian cancer	0.000383	0.0563	CrCbGaD
Budesonide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000382	0.000565	CcSEcCtD
Budesonide—Infection—Epirubicin—ovarian cancer	0.000381	0.000564	CcSEcCtD
Budesonide—Cough—Doxorubicin—ovarian cancer	0.000379	0.000561	CcSEcCtD
Budesonide—Shock—Epirubicin—ovarian cancer	0.000377	0.000558	CcSEcCtD
Budesonide—Nervous system disorder—Epirubicin—ovarian cancer	0.000376	0.000556	CcSEcCtD
Budesonide—Dizziness—Docetaxel—ovarian cancer	0.000376	0.000556	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—ovarian cancer	0.000375	0.000555	CcSEcCtD
Budesonide—Tachycardia—Epirubicin—ovarian cancer	0.000374	0.000554	CcSEcCtD
Budesonide—Skin disorder—Epirubicin—ovarian cancer	0.000372	0.000551	CcSEcCtD
Budesonide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000371	0.000549	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—ovarian cancer	0.00037	0.000548	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—ovarian cancer	0.00037	0.000548	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—ovarian cancer	0.00037	0.000548	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—ovarian cancer	0.000369	0.000546	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000367	0.000544	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—ovarian cancer	0.000365	0.000541	CcSEcCtD
Budesonide—Anorexia—Epirubicin—ovarian cancer	0.000365	0.000541	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—ovarian cancer	0.000362	0.000536	CcSEcCtD
Budesonide—Vomiting—Docetaxel—ovarian cancer	0.000361	0.000535	CcSEcCtD
Budesonide—Rash—Docetaxel—ovarian cancer	0.000358	0.00053	CcSEcCtD
Budesonide—Dermatitis—Docetaxel—ovarian cancer	0.000358	0.00053	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—ovarian cancer	0.000358	0.000529	CcSEcCtD
Budesonide—Headache—Docetaxel—ovarian cancer	0.000356	0.000527	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000355	0.000525	CcSEcCtD
Budesonide—Infection—Doxorubicin—ovarian cancer	0.000352	0.000522	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000349	0.000517	CcSEcCtD
Budesonide—Shock—Doxorubicin—ovarian cancer	0.000349	0.000517	CcSEcCtD
Budesonide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000348	0.000515	CcSEcCtD
Budesonide—Insomnia—Epirubicin—ovarian cancer	0.000347	0.000513	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—ovarian cancer	0.000346	0.000512	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—ovarian cancer	0.000344	0.00051	CcSEcCtD
Budesonide—Paraesthesia—Epirubicin—ovarian cancer	0.000344	0.000509	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000343	0.000508	CcSEcCtD
Budesonide—Dyspnoea—Epirubicin—ovarian cancer	0.000342	0.000506	CcSEcCtD
Budesonide—Somnolence—Epirubicin—ovarian cancer	0.000341	0.000504	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—ovarian cancer	0.000338	0.0005	CcSEcCtD
Budesonide—Nausea—Docetaxel—ovarian cancer	0.000338	0.0005	CcSEcCtD
Budesonide—Dyspepsia—Epirubicin—ovarian cancer	0.000337	0.000499	CcSEcCtD
Budesonide—Decreased appetite—Epirubicin—ovarian cancer	0.000333	0.000493	CcSEcCtD
Budesonide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000331	0.00049	CcSEcCtD
Budesonide—Fatigue—Epirubicin—ovarian cancer	0.00033	0.000489	CcSEcCtD
Budesonide—Pain—Epirubicin—ovarian cancer	0.000328	0.000485	CcSEcCtD
Budesonide—Constipation—Epirubicin—ovarian cancer	0.000328	0.000485	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000323	0.000478	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—ovarian cancer	0.000321	0.000475	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—ovarian cancer	0.000318	0.000471	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—ovarian cancer	0.000316	0.000468	CcSEcCtD
Budesonide—Feeling abnormal—Epirubicin—ovarian cancer	0.000316	0.000468	CcSEcCtD
Budesonide—Somnolence—Doxorubicin—ovarian cancer	0.000315	0.000467	CcSEcCtD
Budesonide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000313	0.000464	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—ovarian cancer	0.000312	0.000462	CcSEcCtD
Budesonide—Decreased appetite—Doxorubicin—ovarian cancer	0.000308	0.000456	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000306	0.000453	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—ovarian cancer	0.000306	0.000453	CcSEcCtD
Budesonide—Urticaria—Epirubicin—ovarian cancer	0.000304	0.000451	CcSEcCtD
Budesonide—Pain—Doxorubicin—ovarian cancer	0.000303	0.000449	CcSEcCtD
Budesonide—Constipation—Doxorubicin—ovarian cancer	0.000303	0.000449	CcSEcCtD
Budesonide—Abdominal pain—Epirubicin—ovarian cancer	0.000303	0.000449	CcSEcCtD
Budesonide—Body temperature increased—Epirubicin—ovarian cancer	0.000303	0.000449	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000292	0.000433	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00029	0.000429	CcSEcCtD
Budesonide—Dexamethasone—ABCB1—ovarian cancer	0.000285	0.042	CrCbGaD
Budesonide—Hypersensitivity—Epirubicin—ovarian cancer	0.000282	0.000418	CcSEcCtD
Budesonide—Urticaria—Doxorubicin—ovarian cancer	0.000282	0.000417	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—ovarian cancer	0.00028	0.000415	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—ovarian cancer	0.00028	0.000415	CcSEcCtD
Budesonide—Asthenia—Epirubicin—ovarian cancer	0.000275	0.000407	CcSEcCtD
Budesonide—Pruritus—Epirubicin—ovarian cancer	0.000271	0.000401	CcSEcCtD
Budesonide—Diarrhoea—Epirubicin—ovarian cancer	0.000262	0.000388	CcSEcCtD
Budesonide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000261	0.000387	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—ovarian cancer	0.000254	0.000377	CcSEcCtD
Budesonide—Dizziness—Epirubicin—ovarian cancer	0.000253	0.000375	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—ovarian cancer	0.000251	0.000371	CcSEcCtD
Budesonide—Vomiting—Epirubicin—ovarian cancer	0.000244	0.000361	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—ovarian cancer	0.000243	0.000359	CcSEcCtD
Budesonide—Rash—Epirubicin—ovarian cancer	0.000242	0.000358	CcSEcCtD
Budesonide—Dermatitis—Epirubicin—ovarian cancer	0.000241	0.000357	CcSEcCtD
Budesonide—Headache—Epirubicin—ovarian cancer	0.00024	0.000355	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—ovarian cancer	0.000235	0.000347	CcSEcCtD
Budesonide—Nausea—Epirubicin—ovarian cancer	0.000228	0.000337	CcSEcCtD
Budesonide—Vomiting—Doxorubicin—ovarian cancer	0.000225	0.000334	CcSEcCtD
Budesonide—Rash—Doxorubicin—ovarian cancer	0.000224	0.000331	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—ovarian cancer	0.000223	0.000331	CcSEcCtD
Budesonide—Headache—Doxorubicin—ovarian cancer	0.000222	0.000329	CcSEcCtD
Budesonide—Nausea—Doxorubicin—ovarian cancer	0.000211	0.000312	CcSEcCtD
